<DOC>
	<DOCNO>NCT00902941</DOCNO>
	<brief_summary>There convince evidence numerous study use psychophysical electrophysiological approach olfaction markedly reduce Parkinson´s disease ( PD ) . Data prevalence olfactory dysfunction PD however , range 45 % 49 % pioneer study Ansari &amp; Johnson , Ward , respectively , 74 % work Hawkes et al. , high 90 % study publish Doty et al . Quality life , safety , interpersonal relation , well food behavior/nutritional intake severely alter large proportion patient olfactory loss . Thus , assume patient Parkinson 's disease . If possible improve olfactory function would appear significant effect patient Parkinson 's disease . Provided study would reveal improvement olfactory function follow therapy rasagiline , would tremendous worldwide impact use drug . Considering frequency PD large number patient would benefit finding , especially term quality life .</brief_summary>
	<brief_title>Olfaction Patients With Parkinson 's Disease Following Treatment With Rasagiline</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Parkinson´s disease , Hoehn &amp; Yahr stage ≤ III age 1864 yr hyposmia/functional anosmia define TDI &lt; 30 write consent congenital olfactory loss significant infection nose nasal sinus diseases/states apart PD may significantly affect olfactory function , e.g. , asthma , head trauma etc . dementia , psychiatric illness , addictive behaviour smoker severe liver disease pregnant breastfeed woman contraindication treatment Rasagiline woman without reliable contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Parkinson´s disease</keyword>
	<keyword>olfaction</keyword>
	<keyword>rasagiline</keyword>
	<keyword>smell test</keyword>
</DOC>